Document Server@UHasselt >
Research publications >
Please use this identifier to cite or link to this item:
|Title: ||Synergistic activity of everolimus and 5-aza-2 '-deoxycytidine in medullary thyroid carcinoma cell lines|
|Authors: ||Vitale, Giovanni|
Grassi, Elisa S.
Borghi, Maria O.
Cantone, Maria C.
Di Blasio, Anna M.
Hofland, Leo J.
|Issue Date: ||2017|
|Citation: ||MOLECULAR ONCOLOGY, 11(8), p. 1007-1022|
|Abstract: ||Medullary thyroid cancer (MTC) is a tumor highly resistant to chemo-and radiotherapy. Drug resistance can be induced by epigenetic changes such as aberrant DNA methylation. To overcome drug resistance, we explored a promising approach based on the use of 5-aza-2'-deoxycytidine (AZA), a demethylating agent, in combination with the mTOR inhibitor everolimus in MTC cells (MZ-CRC-1 and TT). This combined treatment showed a strong synergistic antiproliferative activity through the induction of apoptosis. The effect of everolimus and/or AZA on genome-wide expression profiling was evaluated by Illumina BeadChip in MZ-CRC-1 cells. An innovative bioinformatic pipeline identified four potential molecular pathways implicated in the synergy between AZA and everolimus: PI3K-Akt signaling, the neurotrophin pathway, ECM/receptor interaction, and focal adhesion. Among these, the neurotrophin signaling pathway was most directly involved in apoptosis, through the overexpression of NGFR and Bax genes. The increased expression of genes involved in the NGFRMAPK10-TP53-Bax/Bcl2 pathway during incubation with AZA plus everolimus was validated by western blotting in MZ-CRC-1 cells. Interestingly, addition of a neutralizing anti-NGFR antibody inhibited the synergistic cytotoxic activity between AZA and everolimus. These results open a new therapeutic scenario for MTC and potentially other neuroendocrine tumors, where therapy with mTOR inhibitors is currently approved.|
|Notes: ||[Vitale, Giovanni; Grassi, Elisa S.; Borghi, Maria O.; Cantone, Maria C.; Gaudenzi, Germano; Persani, Luca] Univ Milan, Dept Clin Sci & Community Hlth DISCCO, Milan, Italy. [Vitale, Giovanni; Dicitore, Alessandra; Gelmini, Giulia; Persani, Luca] Ist Auxol Italiano IRCCS, Lab Endocrine & Metab Res, Milan, Italy. [Pepe, Daniele] Hasselt Univ, I BioStat, Hasselt, Belgium. [Gentilini, Davide; Di Blasio, Anna M.] Ist Auxol Italiano, Mol Biol Lab, Milan, Italy. [Borghi, Maria O.] Ist Auxol Italiano IRCCS, Expt Lab Immunorheumatol Res, Milan, Italy. [Misso, Gabriella; Caraglia, Michele] Univ Naples 2, Dept Biochem Biophys & Gen Pathol, Naples, Italy. [Hofland, Leo J.] Erasmus MC, Sect Endocrinol, Dept Internal Med, Rotterdam, Netherlands.|
|ISI #: ||000406633900008|
|Type: ||Journal Contribution|
|Validation: ||ecoom, 2018|
|Appears in Collections: ||Research publications|
Files in This Item:
|Published version||1.07 MB||Adobe PDF|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.